2025 年全球馬尿酸錠劑市場報告

預計未來幾年，烏洛托品磷酸錠劑市場規模將出現強勁成長。預計到 2029 年將成長至 137.8 億美元，複合年成長率為 7.8%。預測期內的成長可歸因於尿路感染盛行率的不斷上升、對抗生素抗藥性的日益擔憂、尿路感染管理的進步、醫療保健重點轉向預防治療、臨床試驗和研究。預測期內的主要趨勢包括泌尿道感染盛行率增加、抗生素抗藥性上升、對非抗生素治療的偏好、對預防性醫療保健的重視以及研究和開發。

預計老年人口的增加將在未來幾年推動馬尿酸烏洛托品錠劑市場的成長。老年族群包括60歲以上的人，由於尿流減少、攝護腺肥大和腎結石等因素，更容易感染尿道感染。因此，用於治療這些疾病的馬尿酸烏洛托品錠劑的需求預計會增加。例如，根據世界衛生組織（WHO）的報告，到2030年，全球65歲及以上人口的比例預計將從2022年的10%上升到2050年的16%。因此，到2050年老年人口的增加預計將成為馬尿酸甲胺錠劑市場成長的主要促進因素。

預計尿道感染（UTI）發病率的不斷增加將推動烏洛托品海馬磷酸鹽錠劑市場的未來成長。尿道感染是一種常見疾病，當細菌進入尿道並感染泌尿道時就會發生，通常從皮膚或直腸開始。海馬烏素錠劑用於預防和治療某些細菌引起的尿道感染。例如，2023年10月，英國政府部門國家醫療服務體系報告稱，2022/23年期間，有147,285人次因尿道結石為主要診斷而入院。其中，65歲以上的老年人佔56%（82,392人），80-84歲年齡層的老年人最多，有17,280人。因此，尿道感染盛行率的上升正在推動烏洛托品市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第 4 章市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球海馬磷酸二甲胺錠劑PESTEL分析（政治，社會，技術，環境，法律因素，促進因素，限制因素）
• 最終用途產業分析
• 全球馬尿酸甲胺錠劑市場：成長率分析
• 全球馬尿酸甲胺錠劑市場表現：規模與成長，2019 年至 2024 年
• 全球馬尿酸甲胺錠劑市場預測：2024-2029 年及 2034 年規模與成長
• 全球馬尿酸錠劑總潛在市場 (TAM)

第6章 市場細分

• 全球馬尿酸甲胺錠劑市場類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 20 片或瓶
• 6 片或瓶
• 全球馬尿酸甲胺錠劑市場：按分銷管道、實際和預測，2019-2024 年、2024-2029 年、2034 年
• 醫院藥房
• 網路藥局
• 零售藥局
• 全球馬尿酸甲胺錠劑市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 無併發症的尿道感染
• 醫療相關性泌尿道感染
• 全球馬尿酸甲胺錠劑市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
• 醫院
• 居家護理
• 專科門診
• 其他最終用戶
• 全球馬尿酸甲胺錠劑市場，按類型細分，20 片/瓶，實際和預測，2019-2024 年，2024-2029F，2034F
• 標準套餐
• 散裝包裝選項
• 全球馬尿酸甲胺錠劑市場，按每瓶 6 片類型細分，實際和預測，2019-2024 年、2024-2029 年、2034 年
• 標準套餐
• 樣品或試用包

第7章 區域和國家分析

• 全球馬尿酸甲胺錠劑市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球馬尿酸甲胺錠劑市場：按國家/地區、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第 17 章 德國市場

第 18 章 法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第 25 章：加拿大市場

第26章 南美洲市場

第 27 章：巴西市場

第28章 中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

• 馬尿酸烏洛托品錠劑市場：競爭格局
• 馬尿酸烏洛托品錠劑市場：公司簡介
  • Alvogen Lux Holdings S.AR.L. Overview, Products and Services, Strategy and Financial Analysis
  • Micro Labs Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Aurobindo Pharma Overview, Products and Services, Strategy and Financial Analysis
  • Amneal Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• McKesson Corporation
• Sun Pharmaceutical Industries Ltd.
• Cipla Ltd.
• Dr. Reddy's Laboratories Ltd.
• Cadila Healthcare Ltd.
• Torrent Pharmaceuticals Ltd.
• Glenmark Pharmaceuticals Ltd.
• Zydus Pharmaceuticals Ltd.
• Lupin Ltd.
• Alkem Laboratories Ltd.
• Ipca Laboratories Ltd.
• Granules India Ltd.
• Teva Pharmaceutical Industries Ltd.
• Apotex Pharmachem Inc.
• Sandoz International GmbH

第 32 章 全球市場競爭基準化分析與儀表板

第33章 重大併購

第 34 章 近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029 年馬尿酸甲胺錠劑市場：提供新機會的國家
• 馬尿酸烏洛托品錠劑市場 2029：細分市場提供新機會
• 馬尿酸甲胺錠劑市場 2029：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第 36 章 附錄

Methenamine hippurate tablets serve as a medication for preventing or controlling recurring urinary tract infections caused by specific bacteria. However, it is not used for treating active infections.

The main types of methenamine hippurate tablets are available in two forms, 20 tablets per bottle and 6 tablets per bottle. Patients can access methenamine hippurate tablets in the form of a 20-tablet bottle. These tablets are distributed through various channels, including hospital pharmacies, online pharmacies, and retail pharmacies. The applications for these tablets include uncomplicated urinary tract infections (UTIs) and healthcare-associated UTIs. The end users encompass hospitals, homecare settings, specialty clinics, and others.

The methenamine hippurate tablets market research report is one of a series of new reports from The Business Research Company that provides methenamine hippurate tablets market statistics, including methenamine hippurate tablets industry global market size, regional shares, competitors with methenamine hippurate tablets market share, detailed methenamine hippurate tablets market segments, market trends, and opportunities, and any further data you may need to thrive in the methenamine hippurate tablets industry. This methenamine hippurate tablets market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The methenamine hippurate tablets market size has grown strongly in recent years. It will grow from $9.52 billion in 2024 to $10.21 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to traditional UTI treatment, antibiotic resistance concerns, clinical validation, physician prescription patterns, patient preference for non-antibiotic solutions.

The methenamine hippurate tablets market size is expected to see strong growth in the next few years. It will grow to $13.78 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to growing UTI prevalence, rising antibiotic resistance concerns, advancements in UTI management, healthcare focus on preventive therapies, clinical trials and research. Major trends in the forecast period include increased UTI incidence, rising antibiotic resistance, preference for non-antibiotic treatments, focus on preventive healthcare, research and development.

The anticipated increase in the geriatric population is poised to drive the growth of the methenamine hippurate tablets market in the coming years. The geriatric population comprises individuals aged 60 and above, who are more susceptible to urinary tract infections due to factors such as reduced urine flow, enlarged prostate, or kidney stones. Consequently, the demand for methenamine hippurate tablets for treating these conditions is expected to rise. For instance, the World Health Organization reports that by 2030, the percentage of the global population aged 65 and above is expected to rise from 10% in 2022 to 16% in 2050. It is projected that by 2050, Thus, the increasing geriatric population is a key driver for the growth of the methenamine hippurate tablets market.

The increasing incidence of urinary tract infections (UTIs) is projected to drive the growth of the methenamine hippurate tablets market in the future. UTIs are common conditions that arise when bacteria enter the urethra and infect the urinary tract, typically originating from the skin or rectum. Methenamine hippurate tablets are utilized to prevent or treat recurring urinary tract infections caused by specific bacteria. For instance, in October 2023, the National Health Service, a UK-based government department, reported that during the 2022/23 period, there were 147,285 admissions for UTIs as the primary diagnosis. Among these, 56% (82,392) were individuals aged 65 and older, with the highest number of admissions occurring in the 80-84 age group, which accounted for 17,280 admissions. Thus, the rising prevalence of urinary tract infections is fueling the growth of the methenamine hippurate market.

Product innovations have become a significant trend gaining traction in the methenamine hippurate tablets market. Leading companies in this sector are developing innovative products to enhance their market position. For example, in May 2023, EQL Pharma, a European pharmaceutical company specializing in cost-effective generic medicines and niche generics for pharmacies and hospitals, announced the out-licensing of Memprex (methenamine hippurate) to Laboratoires Majorelle for distribution in the French market. This move expands the availability of Memprex and provides a non-antibiotic option for UTI prevention. Laboratoires Majorelle, a prominent player in women's health in France, will market and distribute Memprex, offering an alternative for preventing urinary tract infections.

Strategic collaborations have become a significant avenue for major companies operating in the methenamine hippurate tablets market to enhance profitability. These collaborations involve purposeful partnerships between entities to achieve mutual goals through coordinated efforts, leveraging each other's strengths and resources. In May 2023, EQL Pharma AB, a Swedish pharmaceutical company providing methenamine hippurate tablets, entered into a collaboration with Dr. Pfleger Arzneimittel GmbH. Through this collaboration, EQL Pharma AB aims to launch Methenamine Hippurate with an EQL-registered brand within the next two years, involving standard license fees, regulatory and reimbursement milestones, and a volume-dependent supply price upon regulatory approval. Dr. Pfleger Arzneimittel GmbH is a German pharmaceutical company.

In April 2022, Aurelius Group, a German asset management company, acquired McKesson UK for an undisclosed amount. This acquisition is intended to support growth and development across retail, digital, homecare, and wholesale divisions, expanding the healthcare system to enhance patient outcomes. McKesson UK is a UK-based healthcare company providing methenamine hippurate tablets.

Major companies operating in the methenamine hippurate tablets market include Alvogen Lux Holdings S.AR.L., Micro Labs Inc., Aurobindo Pharma, Amneal Pharmaceuticals Inc., Viatris Inc., McKesson Corporation, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Dr. Reddy's Laboratories Ltd., Cadila Healthcare Ltd., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Zydus Pharmaceuticals Ltd., Lupin Ltd., Alkem Laboratories Ltd., Ipca Laboratories Ltd., Granules India Ltd., Teva Pharmaceutical Industries Ltd., Apotex Pharmachem Inc., Sandoz International GmbH

North America was the largest region in the methenamine hippurate tablets market in 2024. The regions covered in the methenamine hippurate tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the methenamine hippurate tablets market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The methenamine hippurate tablets market consists of sales of hexamine hippurate tablets, hiprex tablets, and urinary tract infection tablets. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Methenamine Hippurate Tablets Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on methenamine hippurate tablets market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for methenamine hippurate tablets ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The methenamine hippurate tablets market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: 20 Tablets Or Bottle; 6 Tablets Or Bottle
• 2) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
• 3) By Application: Uncomplicated UTIs; Healthcare-associated UTIs
• 4) By End User: Hospitals; Homecare; Specialty Clinics; Others End Users
• Subsegments:
• 1) By 20 Tablets per Bottle: Standard Packaging; Bulk Packaging Options
• 2) By 6 Tablets per Bottle: Standard Packaging; Sample Or Trial Packaging
• Companies Mentioned: Alvogen Lux Holdings S.AR.L.; Micro Labs Inc.; Aurobindo Pharma; Amneal Pharmaceuticals Inc.; Viatris Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Methenamine Hippurate Tablets Market Characteristics

3. Methenamine Hippurate Tablets Market Trends And Strategies

4. Methenamine Hippurate Tablets Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Methenamine Hippurate Tablets Growth Analysis And Strategic Analysis Framework

• 5.1. Global Methenamine Hippurate Tablets PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Methenamine Hippurate Tablets Market Growth Rate Analysis
• 5.4. Global Methenamine Hippurate Tablets Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Methenamine Hippurate Tablets Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Methenamine Hippurate Tablets Total Addressable Market (TAM)

6. Methenamine Hippurate Tablets Market Segmentation

• 6.1. Global Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20 Tablets Or Bottle
• 6 Tablets Or Bottle
• 6.2. Global Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• 6.3. Global Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Uncomplicated UTIs
• Healthcare-associated UTIs
• 6.4. Global Methenamine Hippurate Tablets Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Others End Users
• 6.5. Global Methenamine Hippurate Tablets Market, Sub-Segmentation Of 20 Tablets per Bottle, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Packaging
• Bulk Packaging Options
• 6.6. Global Methenamine Hippurate Tablets Market, Sub-Segmentation Of 6 Tablets per Bottle, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Packaging
• Sample Or Trial Packaging

7. Methenamine Hippurate Tablets Market Regional And Country Analysis

• 7.1. Global Methenamine Hippurate Tablets Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Methenamine Hippurate Tablets Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Methenamine Hippurate Tablets Market

• 8.1. Asia-Pacific Methenamine Hippurate Tablets Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Methenamine Hippurate Tablets Market

• 9.1. China Methenamine Hippurate Tablets Market Overview
• 9.2. China Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Methenamine Hippurate Tablets Market

• 10.1. India Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Methenamine Hippurate Tablets Market

• 11.1. Japan Methenamine Hippurate Tablets Market Overview
• 11.2. Japan Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Methenamine Hippurate Tablets Market

• 12.1. Australia Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Methenamine Hippurate Tablets Market

• 13.1. Indonesia Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Methenamine Hippurate Tablets Market

• 14.1. South Korea Methenamine Hippurate Tablets Market Overview
• 14.2. South Korea Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Methenamine Hippurate Tablets Market

• 15.1. Western Europe Methenamine Hippurate Tablets Market Overview
• 15.2. Western Europe Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Methenamine Hippurate Tablets Market

• 16.1. UK Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Methenamine Hippurate Tablets Market

• 17.1. Germany Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Methenamine Hippurate Tablets Market

• 18.1. France Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Methenamine Hippurate Tablets Market

• 19.1. Italy Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Methenamine Hippurate Tablets Market

• 20.1. Spain Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Methenamine Hippurate Tablets Market

• 21.1. Eastern Europe Methenamine Hippurate Tablets Market Overview
• 21.2. Eastern Europe Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Methenamine Hippurate Tablets Market

• 22.1. Russia Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Methenamine Hippurate Tablets Market

• 23.1. North America Methenamine Hippurate Tablets Market Overview
• 23.2. North America Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Methenamine Hippurate Tablets Market

• 24.1. USA Methenamine Hippurate Tablets Market Overview
• 24.2. USA Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Methenamine Hippurate Tablets Market

• 25.1. Canada Methenamine Hippurate Tablets Market Overview
• 25.2. Canada Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Methenamine Hippurate Tablets Market

• 26.1. South America Methenamine Hippurate Tablets Market Overview
• 26.2. South America Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Methenamine Hippurate Tablets Market

• 27.1. Brazil Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Methenamine Hippurate Tablets Market

• 28.1. Middle East Methenamine Hippurate Tablets Market Overview
• 28.2. Middle East Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Methenamine Hippurate Tablets Market

• 29.1. Africa Methenamine Hippurate Tablets Market Overview
• 29.2. Africa Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Methenamine Hippurate Tablets Market Competitive Landscape And Company Profiles

• 30.1. Methenamine Hippurate Tablets Market Competitive Landscape
• 30.2. Methenamine Hippurate Tablets Market Company Profiles
  • 30.2.1. Alvogen Lux Holdings S.AR.L. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Micro Labs Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Aurobindo Pharma Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Amneal Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Methenamine Hippurate Tablets Market Other Major And Innovative Companies

• 31.1. McKesson Corporation
• 31.2. Sun Pharmaceutical Industries Ltd.
• 31.3. Cipla Ltd.
• 31.4. Dr. Reddy's Laboratories Ltd.
• 31.5. Cadila Healthcare Ltd.
• 31.6. Torrent Pharmaceuticals Ltd.
• 31.7. Glenmark Pharmaceuticals Ltd.
• 31.8. Zydus Pharmaceuticals Ltd.
• 31.9. Lupin Ltd.
• 31.10. Alkem Laboratories Ltd.
• 31.11. Ipca Laboratories Ltd.
• 31.12. Granules India Ltd.
• 31.13. Teva Pharmaceutical Industries Ltd.
• 31.14. Apotex Pharmachem Inc.
• 31.15. Sandoz International GmbH

32. Global Methenamine Hippurate Tablets Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Methenamine Hippurate Tablets Market

34. Recent Developments In The Methenamine Hippurate Tablets Market

35. Methenamine Hippurate Tablets Market High Potential Countries, Segments and Strategies

• 35.1 Methenamine Hippurate Tablets Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Methenamine Hippurate Tablets Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Methenamine Hippurate Tablets Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer